Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

EENANTA PHARMACEUTICALS, INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
E

ENANTA PHARMACEUTICALS, INC

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $14.36M. Net result −$19.5M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $14.36M. Running result $14.36M. Revenue: $14.36M.
  • Research and development: −$22.13M. Running result −$7.77M.
  • General and administrative: −$9.47M. Running result −$17.24M.
  • Operating income: −$17.24M. Running result −$17.24M.
  • Other expense: −$2.23M. Running result −$19.47M.
  • Pre-tax loss: −$19.47M. Running result −$19.47M.
  • Income tax expense: −$36K. Running result −$19.5M.
  • Net loss: −$19.5M. Running result −$19.5M.